Ticagrelor effectively and reversibly blocks murine platelet P2Y12-mediated thrombosis and demonstrates requirement for sustained P2Y12 inhibition to prevent subsequent neointima - Patil, SB; Jackman, LE; Francis, SE (Arterioscler Thromb Vasc Biol, 2010)
et al.